UnitedHealth Group shares fell about 2% in trading Wednesday morning after the Wall Street Journal reported new details on a previously reported criminal investigation by the U.S. Department of ...

Health-care companies rose as deal activity offset more health-insurance controversy. Merck struck a roughly $10 billion deal to buy Verona Pharma, bolstering its lineup with the chronic obstructive ...

The Dow Jones Industrial Average was erasing most of its morning gains ahead of midday trading on Wednesday. Here's a look at what is putting pressure on the blue-chip index: UnitedHealth Group Inc.'s ...

UnitedHealth Group Inc. promoted a new leader for the company’s Medicaid insurance segment, filling a role that was vacant ...

The investigation, which dates back to at least last summer, concerns alleged efforts to encourage staffers to record certain ...

The Department of Justice is interviewing former employees as part of its criminal Medicare fraud probe into UnitedHealth, according to ...

Merry Kogut filed a derivative suit on June 14, alleging that UnitedHealth's leadership failed to disclose a Department of ...

UnitedHealth Group stock declined on Wednesday following a report from the Wall Street Journal that ex-employees and medical ...

The revised price target follows statements made by UnitedHealth’s reinstated CEO during the company’s annual meeting on June ...

Investigators from the U.S. Department of Justice are questioning former employees of UnitedHealth Group as part of a probe ...

U.S. Department of Justice investigators have questioned former employees at UnitedHealth Group (NYSE:UNH) on Medicare ...

UnitedHealth is under federal investigation for Medicare billing practices, including use of nurses and software to log diagnoses that led to billions in extra payments.